Up next

Point-of-Care Diagnostics Market | Exactitude Consultancy Reports

1 Views· 02/June/23
akshay kadam
akshay kadam
0 Subscribers
0

Exactitude Consultancy Latest Published Point-of-Care Diagnostics Market Research Report 2022 by product (Glucose Monitoring Products, Cardiometabolic Monitoring Products), by platform (Lateral Flow Assays, Dipsticks), by mode of purchase (Prescription-based Products, OTC Products), by end user (Clinical Laboratories and Outpatient, Healthcare & Ambulatory Care Settings) and by Region, Global trends and forecast from 2023 to 2028

The global Point-Of-Care Diagnostics Market is expected to grow at 11.40% CAGR from 2023 to 2028. It is expected to reach above USD 69.9 billion by 2028 from USD 26.4 billion in 2022.

On the basis of product, point-of-care diagnostics market is sub-segmented into glucose monitoring products, cardiometabolic monitoring products, infectious disease testing products, coagulation monitoring products, pregnancy & fertility testing products, tumor/cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drugs-of-abuse testing products, fecal occult testing products, and other poc products. The glucose monitoring products segment accounted for the largest market share in the point-of-care diagnostics market. Factors like the growing popularity of wearable or portable glucose meters due to their speed, easy operation, and less cost, increasing number of POC glucose monitoring devices, coupled with the growing prevalence of diabetes, is expected to drive the growth of the POC diagnostics market for glucose monitoring products in the coming years.

On the basis of platform, point-of-care diagnostics market is categorized into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. The lateral flow assays segment accounted for the largest market share in the point-of-care diagnostics market. Factors driving the growth of the segment include the increasing adoption of lateral flow assays in POC testing as a replacement for lengthy, conventional laboratory procedures.

On the basis of mode of purchase, point-of-care diagnostics is sub-segmented into prescription-based products, OTC products. The OTC products segment accounted for the largest market share in the point-of-care diagnostics. Factor primarily driving the growth of the segment include the increasing adoption of OTC devices across the globe.

To Know more: https://exactitudeconsultancy.....com/reports/1458/poi

Contact us@ sales@exactitudeconsultancy.com

Related Reports:
Boswellia Market - https://exactitudeconsultancy.....com/reports/1073/bos

Respiratory Care Devices Market - https://exactitudeconsultancy.....com/reports/1315/res

Show more

 0 Comments sort   Sort By


Up next